Kerstin Lyttkens (Former)
1 – 5 of 29
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Pre-treatment 18F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancer
(
- Contribution to journal › Article
- 2017
-
Mark
[18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer
(
- Contribution to journal › Article
- 2015
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
[F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy
(
- Contribution to journal › Article